EMAIL DETAILS

When Michael asked me a few weeks ago if we'd introduce him to Ward McNally (not sure how he knew we knew him) I told him (in a nicer way) that it'd really be worthless if we did and that Ward doesn't really have any pools of capital but if he wants to he should feel free to reach out to Ward directly.


Eric D. Schwerin
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com
P Consider the environment before printing this email.


On Feb 16, 2013, at 8:44 AM, Hunter Biden <hbiden@rosemontseneca.com> wrote:

> Why are we cc'd on this?
>
> RHB
> 202.333.1880
>
> Begin forwarded message:
>
>> From: michael solimene <msolimene@ovationbiotech.com>
>> Date: February 15, 2013, 9:14:06 AM MST
>> To: wmcnally@mcnallycapital.com
>> Cc: Hunter Biden <hbiden@rosemontseneca.com>, Eric Schwerin <eschwerin@rosemontseneca.com>, Halton Peters <halton@westjunctioncap.com>, Neil Callahan <ncallahan@rosemontseneca.com>, Glen Meier <gmeier@ovationbiotech.com>
>> Subject: Introduction to Ovation Biotech
>>
>> Ward,
>>
>> I am reaching out to introduce myself and my company, Ovation Biotech, inc. Our company has a patented renewable refining technology that converts nearly any triglyceride into a very valuable molecule called a renewable alkane. Alkanes are the building block ingredient in fuels, oleochemicals and renewable industrial products and our renewable approach is both cost effective and proven. The big difference between us and all the other "bio" based technologies, other than the far superior performance of our products, all of our products do not contain oxygen, which as you know puts massive constraints on fuels and chemical applications. Our business model is a combination of licensing our technology to renewable fuel makers and entering into joint ventures with oleochemical makers as well as specialty oil companies. I have attached a teaser for your review.
>>
>> Next week, I will be in Chicago on Thursday and Friday. If you have time in your schedule and are still investing in renewable strategies, we would welcome the opportunity to share our story with you.
>>
>> Best regards,
>>
>> Michael
>>
>> <Ovation_Teaser_2-1-13.pdf>
>>
>> Michael Solimene
>> Chief Executive Officer
>> Ovation Biotech, Inc
>> Office: 919-899-9750
>> Mobile: 203-257-4337
>> msolimene@ovationbiotech.com
>>
>> Organic Compounds for Energy and Industry
>>
>>
>>